Biomedical goes Technology

Innovative technologies for biomedical engineering

more info

Focus on Stem Cells

Fraunhofer Project Center for Stem Cell Process Engineering

more info

Committed to Highest Quality

Certified and accredited laboratories of Main Department Medical Biotechnology

more info

Automated Biobanking

Technology platform for modern, automated therapeutically and diagnostically-oriented biobanks in industry and research

more info

Ultrasound at its best

Modular ultrasound platform and technologies for medicine, biotechnology, non-destructive testing and sonar applications

more info

Minute, active and compatible

Implantable assistance & monitoring systems, neuroprosthetics, miniaturized systems for cellular biotechnology, biomedical engineering

more info

Personalized medicine - safe at home

Home care, telemedicine platforms, personal health systems, intelligent assistants, communication components for telemedical health care

more info

Diagnostic laboratories on the road

"laboratory of the future", innovative laboratory technologies, sustainable and comprehensive platforms for vertical integration in laboratory technology, mobile epidemiologic laboratories

more info

Lifeline Water

Our seas, oceans and waters are a valuable asset that needs to be explored and to protected. Fraunhofer IBMT deals in many fields with these lifelines. Science Year 2016*17

more info
 

23.3.2020

SARS-CoV-2 and COVID-19 Pandemic: Important Information on Cooperation

Current information on SARS-CoV-2 and COVID-19

The current crisis situation due to SARS-CoV-2 is now also leading to massive restrictions on public life in Germany in order to slow down the further spread of the virus and thus enable our health care system to optimally treat the problem cases of Covid-19. The quality and quantity of clinical care is crucial for the individual chances of those people who suffer a severe course of CoViD-19. Even if the vast majority of us are not at risk, human lives will therefore ultimately depend on our (social) behaviour in this crisis.

Therefore, the management of the Fraunhofer Institute for Biomedical Engineering IBMT has decided - after assessing the available information on the overall situation - to temporarily close the Fraunhofer IBMT with effect from March 17, 2020 (5 p.m.) until April 24, 2020.

The IBMT will reopen at the earliest possible date in order to continue to make its important contribution to biomedical research. We wish you and your relatives good health and, if applicable, a mild course of infection.
 

The Fraunhofer Institute for Biomedical Engineering IBMT acts as a device and technology developer when it comes to the solution of individual research and development projects and tasks from the areas of biomedical/medical engineering, medical (molecular and cellular) biotechnology, biohybrid technology, bioprocessing & bioanalytics, cryo(bio)technology and nano(bio)technology, ultrasound technology, biomedical microsystems, neuroprosthetics and implants, health information systems, theranostics, (mobile) laboratory technology as well as laboratory automation including in-line/on-line process control. For more than 10 years, Fraunhofer IBMT has been working in the field of stem cell research and hosting extensive cell line stocks in industrial and clinically structured biobanks for low temperature storage of valuable samples (fluids, cells, tissue fragments).

360° tour - A virtual tour through laboratories and premises of the Fraunhofer IBMT at Sulzbach

Core Competences

Research and Development

 

Fraunhofer Project Center for Stem Cell Process Engineering

 

Medical Biotechnology

 

Ultrasound

 

Biomedical Engineering

Business Areas

 

Laboratory Technology

 

Theranostics

 

Medical Engineering

Current Topics

 

13.2.2020

Ultrasound serving cultural heritage in museums

From March 2020 onwards, the successful collaboration to preserve cultural heritage within the research alliance "Kulturerbe" (FALKE) will be continued in a second phase. The Fraunhofer Institute for Biomedical Engineering IBMT will offer its researchers’ expertise in the subject area technical ultrasound.


 

 

 

6.2.2020

Künstliche Intelligenz in der Transplantationsmedizin

Effektiv Vorhersagemodelle für Krankheitsverläufe nach Stammzelltransplantation entwickeln und validieren

Dipl.-Inform. Stephan Kiefer, Health Information Systems
Talk at the PharmaForum 2020, 12.03.2020, Mainz, Germany


 

 

 

NanoEDGE: Wearable electronics and printed electrodes for EEG and EMG recordings

Nano-based wearable electronics for mental disorder diagnosis and functional restoration: Production technologies and devices.
 

 

 

MEDICA 2019: Minimally invasive diagnostics with multimodal imaging

Improved biopsies with MRI-compatible ultrasound system. The MRI-compatible ultrasound system will be on display at the MEDICA trade fair in Düsseldorf from November 18 to 21, 2019 (Hall 10, Booth G05).
 

 

Review

New approaches for a more precise radiation therapy of cancer

Ultrasound expertise of the Fraunhofer IBMT in the visionary EU-FET Open Project AMPHORA
(Acoustic markers for enhanced remote sensing of radiation doses).


 

 

New screening approach in the fight against viruses

In the ViroSens project, researchers from the Fraunhofer IBMT and EMFT are working together with industrial partners on a novel analytical method to make the potency testing of vaccines more efficient and cost-effective. The method combines electrochemical sensor technology and biotechnology and, for the first time, enables a completely automated analysis of the infection status of test cells.

 

 

Fraunhofer IBMT in EC-FET Open Project GLADIATOR

The Fraunhofer Institute for Biomedical Engineering IBMT is contributing its expertise in the field of medical biotechnology and ultrasound to a new EC project to work on the next generation theranostics of brain pathologies using autonomous externally controllable nanonetworks.

 

Fraunhofer IBMT auf der BIO International Convention, Philadelphia, USA 2019

Stem cell applications - Application-specific high-throughput production processes revolutionize industrial new drug testing

 

Fraunhofer IBMT at LABVOLUTION 2019

Fraunhofer IBMT, FIT and Project Center SPT present laboratory technologies and biotechnology iin the mobile epidemiological BSL2 laboratory, mobile EpiLab.

 

EBiSC2 – The European Bank for induced pluripotent Stem Cells launches a second project phase

Aim is to become a self-sustainable repository for human induced pluripotent stem cells (hiPSC), extend the existing cell catalogue, and offer additional hiPSC-related services.

 

Personalized Medicine: Effective through Artificial Intelligence in Transplantation Medicine

 

 

Committed to highest quality

Laboratories of Medical Biotechnology of the Fraunhofer IBMT certified and accredited 

 

 

Headquarters Sulzbach (Saarland)

Site St. Ingbert (Saarland)

Project Center Stem Cell Process Engineering Würzburg (Bavaria)

Branch Münster/Wolbeck (North Rhine-Westphalia)

Liaison Office Berlin (Berlin)